ALT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While ALT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALT is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year ALT has reported negative net income.
ALT had a negative operating cash flow in the past year.
ALT had negative earnings in each of the past 5 years.
ALT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -38.41%, ALT is in the better half of the industry, outperforming 60.38% of the companies in the same industry.
The Return On Equity of ALT (-45.21%) is better than 68.76% of its industry peers.

		Industry Rank	Sector Rank
ROA	-38.41%
ROE	-45.21%
ROIC	N/A

ROA(3y)-50.39%

ROA(5y)-43.11%

ROE(3y)-56.08%

ROE(5y)-47.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALT has been increased compared to 5 years ago.
ALT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ALT has an Altman-Z score of 6.01. This indicates that ALT is financially healthy and has little risk of bankruptcy at the moment.
ALT has a Altman-Z score of 6.01. This is in the better half of the industry: ALT outperforms 74.86% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that ALT is not too dependend on debt financing.
The Debt to Equity ratio of ALT (0.08) is worse than 61.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Altman-Z	6.01

ROIC/WACCN/A

WACC8.88%

2.3 Liquidity

A Current Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 17.18, ALT belongs to the best of the industry, outperforming 94.10% of the companies in the same industry.
A Quick Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
ALT's Quick ratio of 17.18 is amongst the best of the industry. ALT outperforms 94.10% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	17.18
Quick Ratio	17.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.15%, which is quite impressive.
The Revenue for ALT has decreased by -61.54% in the past year. This is quite bad
ALT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -67.82% yearly.

EPS 1Y (TTM)20.15%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%34.38%

Revenue 1Y (TTM)-61.54%

Revenue growth 3Y-83.45%

Revenue growth 5Y-67.82%

Sales Q2Q%0%

3.2 Future

The Earnings Per Share is expected to grow by 38.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALT will show a very strong growth in Revenue. The Revenue will grow by 889.71% on average per year.

EPS Next Y26.03%

EPS Next 2Y3.59%

EPS Next 3Y5.36%

EPS Next 5Y38.08%

Revenue Next Year112.6%

Revenue Next 2Y0%

Revenue Next 3Y1778.25%

Revenue Next 5Y889.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALT. In the last year negative earnings were reported.
Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.